Drug Profile
GM 1677
Latest Information Update: 07 Feb 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Anti-inflammatories
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Inflammation in Canada (Unknown route)
- 08 Jun 1995 New profile
- 08 Jun 1995 No-Development-Reported for Inflammation in Canada (Unknown route)